TANIA MARTINEZ: Open Payments
NPI 1043853666 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$746 in 22 payments from 10 companies in 2025. Trend: 2023 $15 · 2024 $387 · 2025 $746
Food & beverage: $746
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 5 | $412 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $89 |
| ABBVIE INC. | 3 | $53 |
| Exact Sciences Corporation | 2 | $51 |
| Otsuka America Pharmaceutical, Inc. | 2 | $37 |
| Viatris Specialty LLC | 2 | $36 |
| Vertical Pharmaceuticals, LLC | 1 | $21 |
| SANOFI-AVENTIS U.S. LLC | 1 | $20 |
| Cranial Technologies, Inc | 1 | $15 |
| Cumberland Pharmaceuticals, Inc. | 1 | $14 |
Products named: BREZTRI, AIRSUPRA, CAPLYTA, VRAYLAR, Cologuard Collection Kit, REXULTI, YUPELRI, Relexxii.
Industry payments across TX — which companies pay providers there.
